Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Canagliflozin Hemihydrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,770Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8Canaglu

    02 23Canalia

    03 1Invokana / Invokamet

    04 7Invokana/Invokamet

    05 1Royalty From Invokana

    06 8Royalty from Invokana

    07 13Tenelia

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Canalia

    Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Canalia

    Japan
    arrow
    VMX
    Not Confirmed

    Daiichi Sankyo

    Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 137

    2019 Revenue in Millions : 112

    Growth (%) : 22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Tenelia

    Teneligliptin, Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Tenelia

    Japan
    arrow
    VMX
    Not Confirmed

    Daiichi Sankyo

    Teneligliptin, Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 222

    2019 Revenue in Millions : 230

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Canalia

    Teneligliptin, Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Canalia

    Japan
    arrow
    VMX
    Not Confirmed

    Daiichi Sankyo

    Teneligliptin, Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 137

    2019 Revenue in Millions : 112

    Growth (%) : 22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Invokana/Invokamet

    Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Invokana/Invokamet

    U.S.A
    arrow
    VMX
    Not Confirmed

    Johnson & Johnson

    Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 795

    2019 Revenue in Millions : 735

    Growth (%) : 8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Canalia

    Teneligliptin, Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Canalia

    Japan
    arrow
    VMX
    Not Confirmed

    Daiichi Sankyo

    Teneligliptin, Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 139

    2020 Revenue in Millions : 136

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Tenelia

    Teneligliptin, Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Tenelia

    Japan
    arrow
    VMX
    Not Confirmed

    Mitsubishi Tanabe

    Teneligliptin, Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 138

    2019 Revenue in Millions : 147

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Canalia

    Teneligliptin, Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Canalia

    Japan
    arrow
    VMX
    Not Confirmed

    Mitsubishi Tanabe

    Teneligliptin, Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 80

    2019 Revenue in Millions : 69

    Growth (%) : 16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Tenelia

    Teneligliptin, Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Tenelia

    Japan
    arrow
    VMX
    Not Confirmed

    Daiichi Sankyo

    Teneligliptin, Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 200

    2020 Revenue in Millions : 220

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Royalty from Invokana

    Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Royalty from Invokana

    Japan
    arrow
    VMX
    Not Confirmed

    Mitsubishi Tanabe

    Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 86

    2019 Revenue in Millions : 80

    Growth (%) : 7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Canalia

    Canagliflozin

    arrow
    VMX
    Not Confirmed

    Brand Name : Canalia

    Japan
    arrow
    VMX
    Not Confirmed

    Daiichi Sankyo

    Canagliflozin

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 139

    2020 Revenue in Millions : 136

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.